These observations, together with our siRNA experiments in HNSCC cell lines, suggest that in SCC at least, APOBEC3A expression is confined to the minority of tumour cells in which GRHL3 is expressed and active. This evidence concerns the gene GRHL3 and head and neck squamous cell carcinoma.